These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29655499)

  • 1. Genetic Testing in Clinical Settings.
    Franceschini N; Frick A; Kopp JB
    Am J Kidney Dis; 2018 Oct; 72(4):569-581. PubMed ID: 29655499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pharmacogenomics in adverse drug reactions.
    Cacabelos R; Cacabelos N; Carril JC
    Expert Rev Clin Pharmacol; 2019 May; 12(5):407-442. PubMed ID: 30916581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitating clinical implementation of pharmacogenomics.
    Mrazek DA; Lerman C
    JAMA; 2011 Jul; 306(3):304-5. PubMed ID: 21771991
    [No Abstract]   [Full Text] [Related]  

  • 4. How Should Primary Care Physicians Respond to Direct-to-Consumer Genetic Test Results?
    Brothers KB; Knapp EE
    AMA J Ethics; 2018 Sep; 20(9):E812-818. PubMed ID: 30242811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches to molecular diagnosis.
    Korf BR; Rehm HL
    JAMA; 2013 Apr; 309(14):1511-21. PubMed ID: 23571590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals: A Randomized Clinical Trial.
    Nadkarni GN; Fei K; Ramos MA; Hauser D; Bagiella E; Ellis SB; Sanderson S; Scott SA; Sabin T; Madden E; Cooper R; Pollak M; Calman N; Bottinger EP; Horowitz CR
    JAMA Netw Open; 2022 Mar; 5(3):e221048. PubMed ID: 35244702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics approach to therapeutics.
    Koo SH; Lee EJ
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):525-32. PubMed ID: 16700889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
    Swen JJ; van der Wouden CH; Manson LE; Abdullah-Koolmees H; Blagec K; Blagus T; Böhringer S; Cambon-Thomsen A; Cecchin E; Cheung KC; Deneer VH; Dupui M; Ingelman-Sundberg M; Jonsson S; Joefield-Roka C; Just KS; Karlsson MO; Konta L; Koopmann R; Kriek M; Lehr T; Mitropoulou C; Rial-Sebbag E; Rollinson V; Roncato R; Samwald M; Schaeffeler E; Skokou M; Schwab M; Steinberger D; Stingl JC; Tremmel R; Turner RM; van Rhenen MH; Dávila Fajardo CL; Dolžan V; Patrinos GP; Pirmohamed M; Sunder-Plassmann G; Toffoli G; Guchelaar HJ;
    Lancet; 2023 Feb; 401(10374):347-356. PubMed ID: 36739136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic studies in chronic kidney disease: interpretation and clinical applicability.
    Witasp A; Nordfors L; Carrero JJ; Luttropp K; Lindholm B; Schalling M; Stenvinkel P
    J Nephrol; 2012; 25(6):851-64. PubMed ID: 23042432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics: bridging the gap between science and practice.
    Lee KC; Ma JD; Kuo GM
    J Am Pharm Assoc (2003); 2010; 50(1):e1-14; quiz e15-7. PubMed ID: 20368146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics in Older Adults: An Integrative Review.
    Inventor BR; Paun O
    Res Gerontol Nurs; 2021; 14(4):211-220. PubMed ID: 34288783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General considerations for integrating pharmacogenomics into mainstream medical practice.
    Patrinos GP
    Hum Genomics; 2010 Aug; 4(6):371-4. PubMed ID: 20846925
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical association between pharmacogenomics and adverse drug reactions.
    Zhou ZW; Chen XW; Sneed KB; Yang YX; Zhang X; He ZX; Chow K; Yang T; Duan W; Zhou SF
    Drugs; 2015 Apr; 75(6):589-631. PubMed ID: 25895462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics and ESKD Disparities in African Americans.
    Umeukeje EM; Young BA
    Am J Kidney Dis; 2019 Dec; 74(6):811-821. PubMed ID: 31606237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in chronic pain therapy: from disease to treatment and challenges for clinical practice.
    Yamamoto PA; Conchon Costa AC; Lauretti GR; de Moraes NV
    Pharmacogenomics; 2019 Aug; 20(13):971-982. PubMed ID: 31486733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
    Dunnenberger HM; Crews KR; Hoffman JM; Caudle KE; Broeckel U; Howard SC; Hunkler RJ; Klein TE; Evans WE; Relling MV
    Annu Rev Pharmacol Toxicol; 2015; 55():89-106. PubMed ID: 25292429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pharmacogenomics in dialysis and transplantation.
    Birdwell K
    Curr Opin Nephrol Hypertens; 2014 Nov; 23(6):570-7. PubMed ID: 25162201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic literacy series: clinical application of pharmacogenetics for adverse reactions to antiepileptic drugs.
    Zhang Z; Wu Y; Tan NC; Jiang Y
    Epileptic Disord; 2019 Aug; 21(4):330-336. PubMed ID: 31403464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues.
    Bunnik EM; Schermer MH; Janssens AC
    BMC Med Ethics; 2011 Jun; 12():11. PubMed ID: 21672210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.